Cancer Immunology, Immunotherapy

Immunotherapeutic potential of whole tumour cells

Stephen Ward, David Casey, Marie-Christine Labarthe, Michael Whelan, Angus Dalgleish, Hardev Pandha, Stephen Todryk

Anti-tumor activities of the angiogenesis inhibitors interferon-inducible protein-10 and the calreticulin fragment vasostatin

Lei Yao, Sandra E. Pike, Stefania Pittaluga, Barry Cherney, Ghanshyam Gupta, Elaine S. Jaffe, Giovanna Tosato

Cell fusion: an approach to generating constitutively proliferating human tumor antigen-presenting cells

P. Jantscheff, G. Spagnoli, P. Zajac, C. Rochlitz

Protein A-induced apoptosis of cancer cells is effected by soluble immune mediators

Tanya Das, Gaurisankar Sa, Sreya Chattopadhyay, Prasanta K. Ray

Suppression of in vivo tumorigenicity of rat hepatoma cell line KDH-8 cells by soluble TGF-β receptor type II

Wenli Zhao, Masonobu Kobayashi, Wei Ding, Lan Yuan, Prem Seth, Santoso Cornain, Jingxin Wang, Futoshi Okada, Masuo Hosokawa

Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21

Isabel Maleno, Miguel López-Nevot, Teresa Cabrera, José Salinero, Federico Garrido

14th Pezcoller Symposium: The Novel Dichotomy of Immune Interactions with Tumors 30 May–1 June 2002, Trento, Italy